BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31680449)

  • 1. Best practices to optimize utilization of the National Living Donor Assistance Center for the financial assistance of living organ donors.
    Mathur AK; Stewart Lewis ZA; Warren PH; Walters MC; Gifford KA; Xing J; Goodrich NP; Bennett R; Brownson A; Ellefson J; Felan G; Gray B; Hays RE; Klein-Glover C; Lagreco S; Metzler N; Provencher K; Walz E; Warmke K; Merion RM; Ojo AO
    Am J Transplant; 2020 Jan; 20(1):25-33. PubMed ID: 31680449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The National Living Donor Assistance Center perspective on barriers to the use of federal travel grants for living donors.
    Mathur AK; Hong B; Ojo A; Merion RM
    Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28485106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Return on investment for financial assistance for living kidney donors in the United States.
    Mathur AK; Xing J; Dickinson DM; Warren PH; Gifford KA; Hong BA; Ojo A; Merion RM
    Clin Transplant; 2018 Jul; 32(7):e13277. PubMed ID: 29740879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to the use of a federal travel grant by living kidney donors.
    Hays RE; Thomas AE; Mathias E; Mezrich J; Mandelbrot DA
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27888522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial compensation for organ donors.
    Harbell JW; Mathur AK
    Curr Opin Organ Transplant; 2019 Apr; 24(2):182-187. PubMed ID: 30762665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial Neutrality for Living Organ Donors: Reasoning, Rationale, Definitions, and Implementation Strategies.
    Hays R; Rodrigue JR; Cohen D; Danovitch G; Matas A; Schold J; LaPointe Rudow D
    Am J Transplant; 2016 Jul; 16(7):1973-81. PubMed ID: 27037542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the National Living Donor Assistance Center: reducing financial disincentives to living organ donation.
    Warren PH; Gifford KA; Hong BA; Merion RM; Ojo AO
    Prog Transplant; 2014 Mar; 24(1):76-81. PubMed ID: 24598569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Federal Reimbursement for Living Donor Costs by Racial and Ethnic Minorities: Implications for Disparities in Access to Living Donor Transplantation.
    Mathur AK; Goodrich N; Hong B; Smith AR; Mandell RJ; Warren PH; Gifford KA; Ojo AO; Merion RM
    Transplantation; 2024 May; ():. PubMed ID: 38771064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wages, Travel, and Lodging Reimbursement by the National Kidney Registry: An Important Step Toward Financial Neutrality for Living Kidney Donors in the United States.
    Garg N; Waterman AD; Ranasinghe O; Warnke L; Morris J; Cooper M; Mandelbrot DA
    Transplantation; 2021 Dec; 105(12):2606-2611. PubMed ID: 33675322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predonation Direct and Indirect Costs Incurred by Adults Who Donated a Kidney: Findings From the KDOC Study.
    Rodrigue JR; Schold JD; Morrissey P; Whiting J; Vella J; Kayler LK; Katz D; Jones J; Kaplan B; Fleishman A; Pavlakis M; Mandelbrot DA;
    Am J Transplant; 2015 Sep; 15(9):2387-93. PubMed ID: 25943721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living and deceased organ donation should be financially neutral acts.
    Delmonico FL; Martin D; Domínguez-Gil B; Muller E; Jha V; Levin A; Danovitch GM; Capron AM
    Am J Transplant; 2015 May; 15(5):1187-91. PubMed ID: 25833381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Providing Coverage for the Unique Lifelong Health Care Needs of Living Kidney Donors Within the Framework of Financial Neutrality.
    Gill JS; Delmonico F; Klarenbach S; Capron AM
    Am J Transplant; 2017 May; 17(5):1176-1181. PubMed ID: 27888569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TALKS study to improve communication, logistical, and financial barriers to live donor kidney transplantation in African Americans: protocol of a randomized clinical trial.
    Strigo TS; Ephraim PL; Pounds I; Hill-Briggs F; Darrell L; Ellis M; Sudan D; Rabb H; Segev D; Wang NY; Kaiser M; Falkovic M; Lebov JF; Boulware LE
    BMC Nephrol; 2015 Oct; 16():160. PubMed ID: 26452366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing the Costs of Routine Follow-up Care After Living Kidney Donation: a Review and Survey of Contemporary Experience, Practices, and Challenges.
    Lentine KL; Sarabu N; McNatt G; Howey R; Hays R; Thomas CP; Lebron-Banks U; Ohler L; Wooley C; Wisniewski A; Xiao H; Tietjen A
    Curr Transplant Rep; 2022; 9(4):328-335. PubMed ID: 36187071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living-Donor Kidney Transplantation: Reducing Financial Barriers to Live Kidney Donation--Recommendations from a Consensus Conference.
    Tushla L; Rudow DL; Milton J; Rodrigue JR; Schold JD; Hays R;
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1696-702. PubMed ID: 26002904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living donor financial assistance programs in liver transplantation: The global perspective.
    Emamaullee J; Tenorio L; Khan S; Butler C; Kim S; Tucker-Seeley R; Kwon Y; Shapiro J; Saigal S; Sher L; Genyk Y
    Clin Transplant; 2020 Nov; 34(11):e14073. PubMed ID: 32882091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Donation and Transplant Outcomes in Trinidad and Tobago: A 15-Year Experience of the National Organ Transplant Unit.
    Elcock-Straker B; Manyalich Vidal M; Gomez MP
    Exp Clin Transplant; 2022 Jul; 20(7):649-656. PubMed ID: 35924742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial Costs Incurred by Living Kidney Donors: A Prospective Cohort Study.
    Przech S; Garg AX; Arnold JB; Barnieh L; Cuerden MS; Dipchand C; Feldman L; Gill JS; Karpinski M; Knoll G; Lok C; Miller M; Monroy M; Nguan C; Prasad GVR; Sarma S; Sontrop JM; Storsley L; Klarenbach S;
    J Am Soc Nephrol; 2018 Dec; 29(12):2847-2857. PubMed ID: 30404908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Long-Term Follow-up and Support for Living Organ Donors: A Center-Based Initiative Founded on Developing a Community of Living Donors.
    Kulkarni S; Thiessen C; Formica RN; Schilsky M; Mulligan D; D'Aquila R
    Am J Transplant; 2016 Dec; 16(12):3385-3391. PubMed ID: 27500361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis.
    Axelrod DA; Schnitzler MA; Xiao H; Naik AS; Segev DL; Dharnidharka VR; Brennan DC; Lentine KL
    Am J Transplant; 2017 Feb; 17(2):377-389. PubMed ID: 27565133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.